User:Mr. Ibrahem/Tedizolid

Tedizolid, sold under the brand name Sivextro, is an antibiotic used for skin and skin structure infection including cellulitis and skin abscesses. This includes cases due to meticillin-resistant Staphylococcus aureus (MRSA). It can be given by mouth or by gradual injection into a vein.

Common side effects include nausea, headache, diarrhea, and vomiting. Other side effects may include Clostridioides difficile infection. Safety in pregnancy and breastfeeding is unclear. It is in the oxazolidinone class of medications and works by blocking bacteria from making protein.

Tedizolid was approved for medical use in the United States in 2014 and Canada and Europe in 2015. It is on the World Health Organization's List of Essential Medicines as an alternative to linezolid. In the United States a 6 day course of treatment costs about 2,300 USD as of 2021. This amount in the United Kingdom costs the NHS about £862.